StockTipsArenaBeta

Emcure Pharmaceuticals LimitedShare price targets & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹1,926.8-0.80 (-0.04%)
Analysts lean BUY·all 7 long-term calls are BUY·consensus 1Y target ₹2,231.43 (15.8% above CMP)
₹2,231.43
15.8% above CMP
₹2,030 – ₹2,320
7 active 1Y targets
8 open
8 BUY · 0 SELL (all horizons)
40%
4 of 10 closed calls hit
Watch EMCURE for new buy/sell callsGet alertsSee 52 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

All tips (20) · loading…

BUYEMCUREEmcure Pharmaceuticals1 Year* (horizon not stated by the source; assumed from the target's distance)
AI6+·0−-0.0% P&L+19.6% upside left
₹1,926.8
CMP
Entry*
₹1,927.6
Target
₹2,305
ISICICI Securities· via Institutional / Brokerage Research3d ago
BUYEMCUREEmcure Pharmaceuticals1 Year* (horizon not stated by the source; assumed from the target's distance)
AI6+·0−+0.0% P&L+19.6% upside left
₹1,926.8
CMP
Entry*
₹1,925.9
Target
₹2,305
MOMotilal Oswal· via Economic Times New Stock Recos3d ago
BUYEMCUREEmcure Pharmaceuticals1 Year* (horizon not stated by the source; assumed from the target's distance)
AI6+·0−+2.5% P&L+5.4% upside left
₹1,926.8
CMP
Entry*
₹1,878.9
Target
₹2,030
ECElara Capital· via ET Now (Live)1w ago
BUYEMCUREEmcure Pharmaceuticals1 Year* (horizon not stated by the source; assumed from the target's distance)
AI6+·0−-2.6% P&L+20.4% upside left
₹1,926.8
CMP
Entry*
₹1,977.8
Target
₹2,320
JIJefferies India· via Financial Express Market4w ago
BUYEMCUREEmcure Pharmaceuticals1 Year* (horizon not stated by the source; assumed from the target's distance)
AI6+·0−-0.5% P&L+19.4% upside left
₹1,926.8
CMP
Entry*
₹1,936.7
Target
₹2,300
MOMotilal Oswal· via Institutional / Brokerage Research4w ago
BUYEMCUREEmcure Pharmaceuticals1 Year* (horizon not stated by the source; assumed from the target's distance)
AI6+·0−+8.1% P&L+17.3% upside left
₹1,926.8
CMP
Entry*
₹1,783.2
Target
₹2,260
MOMotilal Oswal· via Institutional / Brokerage Research7w ago
BUYEMCUREEmcure Pharmaceuticals1 Year* (horizon not stated by the source; assumed from the target's distance)
AI6+·0−+7.6% P&L+9.0% upside left
₹1,926.8
CMP
Entry
₹1,791
Target
₹2,100
JIJefferies India· via NDTV Profit (Live)10w ago
BUYEMCUREEmcure Pharmaceuticals1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI9+·2−+18.41% realised0.0% upside left
Entry*
₹1,659.5
Target
₹1,965
hit 31 Jul 2026, 12:07 pm
BCBOB Capital Markets· via Institutional / Brokerage Research17w ago
BUYEMCUREEmcure Pharmaceuticals1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+20.56% realised0.0% upside left
Entry*
₹1,482.3
Target
₹1,787
hit 4 May 2026, 12:05 pm
BCBOB Capital Markets· via Institutional / Brokerage Research30w ago
BUYEMCUREEmcure Pharmaceuticals1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+22.85% realised0.0% upside left
Entry*
₹1,337.4
Target
₹1,643
hit 27 Mar 2026, 12:03 pm
BCBOB Capital Markets· via Institutional / Brokerage Research42w ago
BUYEMCUREEmcure Pharmaceuticals1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+17.30% realised0.0% upside left
Entry*
₹1,304.3
Target
₹1,530
hit 6 Jan 2026, 12:01 pm
BCBOB Capital Markets· via Institutional / Brokerage Research48w ago
BUYEMCUREEmcure Pharmaceuticals1–3 Months* (horizon not stated by the source; assumed from the target's distance)⏳ Pending entry
AI4+·1−— P&LNA upside left
₹1,926.8
CMP
Entry
₹1,700
Target
₹2,200
VPVaishali Parekh, Prabhudas Lilladher· via NDTV Profit (Live)8w ago
BUYEMCUREEmcure Pharmaceuticals1–3 MonthsStop-loss hit
-4.58% realisedNA upside left
SL
₹1,500
Entry*
₹1,572
Target
₹1,750
hit 21 Apr 2026, 12:00 am
ABAkshay Bhagwat, JM Financial· via Business Today21w ago
BUYEMCUREEmcure Pharmaceuticals1–3 MonthsExpired○ No trade
AI6+·1−— realisedNA upside left
Entry
₹1,630
Target
₹1,750
SHSwati Hotkar, Nirmal Bang Securities· via NDTV Profit (Live)13w ago
BUYEMCUREEmcure Pharmaceuticals1–3 Months* (horizon not stated by the source; assumed from the target's distance)Expired
+14.18% realisedNA upside left
₹1,790.3
At expiry
Entry*
₹1,568
Target
₹2,000
expired 15 Jul 2026, 3:30 pm
AJAnshul Jain, Lakshmishree Investment and Securities· via Business Today20w ago
BUYEMCUREEmcure Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI5+·0−-4.49% realisedNA upside left
SL
₹1,915
Entry*
₹2,005
Target
₹2,135
hit 17 Aug 2026, 9:15 am
KBKush Bohra· via NDTV Profit (Live)4w ago
BUYEMCUREEmcure Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
-7.50% realisedNA upside left
SL
₹1,475
Entry*
₹1,594.6
Target
₹1,700
hit 2 Apr 2026, 10:25 am
ABAkshay Bhagwat, JM Financial· via Business Today23w ago
BUYEMCUREEmcure Pharmaceuticals1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Expired
+0.94% realisedNA upside left
₹1,833.6
At expiry
Entry*
₹1,816.6
Target
₹2,000
expired 7 Jul 2026, 3:30 pm
MJManas Jaiswal· via CNBC Awaaz.10w ago
BUYEMCUREEmcure PharmaceuticalsIntradayExpired
AI2+·0−-0.32% realisedNA upside left
₹1,928.6
At expiry
SL
₹1,898
Entry*
₹1,934.8
Target
₹1,985
expired 7 Sept 2026, 3:20 pm
SJSandeep Jain, Tradeswift· via Zee Business (Live)8h ago
BUYEMCUREEmcure PharmaceuticalsIntradayExpired○ No trade
— realisedNA upside left
SL
₹1,716
Entry
₹1,741
Target
₹1,794
AKArun Kumar Mantri· via CNBC Awaaz.13w ago
StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.